Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Proviral DNA as a Target for HIV-1 Resistance Analysis (HIV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04088916
Recruitment Status : Recruiting
First Posted : September 13, 2019
Last Update Posted : September 17, 2019
Sponsor:
Collaborator:
ViiV Healthcare
Information provided by (Responsible Party):
PABLO ANDRES FERRER CAMPOS, University of Chile

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Actual Primary Completion Date : September 8, 2019
Estimated Study Completion Date : December 31, 2022